发明名称 |
A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3β-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS |
摘要 |
5-cholesten, 3β, 25-diol, disulfate (25HCDS) has been found to be an authentic PPARϒ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases. |
申请公布号 |
IN2366KON2014(A) |
申请公布日期 |
2015.05.01 |
申请号 |
IN2014KOLNP2366 |
申请日期 |
2014.10.27 |
申请人 |
VIRGINA COMMONWEALTH UNIVERSITY |
发明人 |
REN, SHUNLIN |
分类号 |
C07J31/00;C07C401/00 |
主分类号 |
C07J31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|